Conclusion First

The central question for Mimaki is not top-line growth. It is the sustainability of ink revenue.

PointView
EarningsFY2026 revenue slightly down, operating profit up, operating margin 11.3%
StrengthCombination of industrial printers, ink, and maintenance
Valuation lensShift from equipment maker to company with stock-like revenue
KPIsink sales, consumables ratio, installed base, operating margin
Riskscapex cycle, Chinese price competition, FX, compatible inks

The current view is mildly positive but still neutral.

The story is strong and the numbers are not bad. However, if the stock price has already priced in the story, ink-sales ratio and progress on MI30 must exceed market expectations.

What Happened?

For the fiscal year ended March 2026, Mimaki reported:

ItemFY2026YoY
Revenue83.725 billion yen-0.3%
Operating profit9.431 billion yen+3.5%
Ordinary profit8.907 billion yen+5.5%
Net income6.741 billion yen+9.5%
Operating margin11.3%improving
ROE18.7%high

Revenue does not look flashy. It was slightly down year on year.

But operating profit increased. That matters.

When profit rises despite flat revenue, something is improving in pricing, cost, mix, consumables, or SG&A absorption. For Mimaki, the central explanation is ink revenue.

Printers Are the Entry Point

If Mimaki is viewed only as a company that sells industrial printers, the analysis is shallow.

The more important part is what happens after the printer is sold: ink, maintenance, and consumables.

Industrial printers operate at customer sites for years. If they operate, they consume ink. In areas where quality, color reproduction, material compatibility, and maintenance matter, customers do not simply choose the cheapest ink.

Printer sales
↓
Installed base increases
↓
Ink consumption increases
↓
Consumables revenue accumulates
↓
Profit margin is supported

The company has shown that ink sales had expanded to 31.598 billion yen by FY2025. Ink is already a major part of the revenue base.

Without this point, Mimaki's valuation is easy to misread.

Why Margins Can Improve

Mimaki has a clear leverage structure.

First, hardware sales increase the installed base.

Second, a larger installed base increases the physical base for ink sales.

Third, ink revenue comes from existing customers and tends to require less selling effort than new hardware sales.

As the share of ink and consumables rises, operating margin can be supported.

Of course, the story is not automatic. Raw-material prices, FX, inventory, regional mix, product mix, and price competition can all affect margins.

Mimaki's strength is not selling printers and ink separately. It is providing printers, ink, control technology, material compatibility, and maintenance as a combined solution.

MI30 as the Market's Yardstick

Mimaki's medium-term growth strategy is "Mimaki Innovation 30" (MI30).

MI30 pointContent
PeriodFY2026 to FY2030
Revenue target150 billion yen in FY2030
Margin targetoperating margin of 8% or more
Investment policyexisting development plus 1-2% of revenue into new areas
New areasDigital Paint, high-viscosity fields, 3D, peripherals

What is interesting is that FY2026 operating margin was already 11.3%, above the MI30 margin target.

The issue is whether Mimaki can grow sales while maintaining quality of profit.

If the path to 150 billion yen revenue becomes clearer and ink revenue remains strong, Mimaki may be valued less as a machinery stock and more as a high-margin industrial digital printing platform.

If growth requires lower-margin machines and price competition, the valuation becomes more difficult.

KPIs Investors Should Watch

KPIWhy it matters
Ink salesthickness of stock-like revenue
Ink revenue ratiosupport for company-wide margin
Printer unit salesentry point for future ink revenue
Sales by marketwhich areas are growing
Operating marginwhether mix and consumables support profit
Operating cash flowwhether profit becomes cash
R&D expensewhether MI30 investment continues
Overseas sales ratioFX and regional demand sensitivity

The most important are ink sales and operating margin.

Hardware sales alone are not enough if they do not lead to ink revenue. Conversely, even if hardware sales slow temporarily, stable ink sales from the installed base can support earnings.

Sales before ink. Ink before cash.

Main Risk: Price Competition From Chinese Manufacturers

In industrial machinery, entry models are prone to price competition.

Chinese manufacturers may gain share with lower-priced products. If printing quality and durability become sufficient, some customers may shift to cheaper machines.

Mimaki's moat is not only printer price.

MoatContent
Ink technologyfunctional inks suited to materials
Color reproductionstable quality required in industrial use
Head controlprecise discharge control
Maintenance networksupport for global installed base
Material compatibilitysignage, industrial products, textiles, and more

Industrial customers care about uptime, stable color, material fit, defect rates, and delivery schedules.

But if the price gap becomes too large, the story changes. Low-cost products entering Mimaki's high-value areas would pressure the ink revenue model.

Overall View

Mimaki does not need to be viewed only as a machinery maker. The more interesting thesis is the installed-base and ink-consumables model.

However, the market will not keep paying for the story unless ink revenue, margin quality, and MI30 progress keep confirming it.

The investment stance is positive-leaning neutral. The business model is attractive, but future valuation depends on whether the company can grow without sacrificing the profitability that makes the ink model valuable.

Sources and Notes

This article is an investment strategy note based on Mimaki Engineering's FY2026 results, company materials, and previously published Kabutrack quarterly summary. It is not a recommendation to buy or sell any security.

This article is for educational and informational purposes only, based on public information. It is not a recommendation or solicitation to buy or sell any specific security or financial product. Although care is taken with accuracy, the content and future investment outcomes are not guaranteed. Final investment decisions should be made at your own judgment and responsibility.